Christopher Baladad, PharmD, BCIDP
cbaladadpharmd.bsky.social
Christopher Baladad, PharmD, BCIDP
@cbaladadpharmd.bsky.social
Antimicrobial stewardship pharmacist in San Diego, CA | PGY1 Penn State Hershey '21 | PGY2 ID UF Health Shands '22 | Views are my own | he/him | 🏳️‍🌈
I love chatGPT so much for AI-generated images.
June 30, 2025 at 10:39 PM
Reposted by Christopher Baladad, PharmD, BCIDP
Executive Summary of State-of-the-Art Review: Modern Approach to Nocardiosis—Diagnosis, Management, and Uncertainties

⭐ Editor's Choice
#IDSky
Executive Summary of State-of-the-Art Review: Modern Approach to Nocardiosis—Diagnosis, Management, and Uncertainties
Nocardia is a genus of gram-positive, partially acid-fast bacilli that typically infect people with chronic lung disease or immunocompromised states.
academic.oup.com
May 24, 2025 at 6:58 PM
Reposted by Christopher Baladad, PharmD, BCIDP
🆕💫 Narrative review in ICM
How to approach a patient hospitalized for pneumonia who is not responding to treatment? #idsky #EMIMCC
link.springer.com/article/10.1...
May 24, 2025 at 8:08 PM
What I wish I had right now, an already made newsletter on "Things We Do For No Reason: 'Continue IV Antibiotics While Inpatient, Then Discharge Home on Oral Antibiotics'" in patients that can otherwise tolerate oral therapy. Fewer lines, shorter stays, same outcomes. #IDSky #PharmSky
April 10, 2025 at 5:37 PM
For institutions that have sulbactam-durlobactam on formulary.

What are your criteria for use? Do you use it first line for all CRABs? Has it replaced high dose ampicillin-sulbactam?

#IDSky #Pharmsky
March 4, 2025 at 6:06 PM
Reposted by Christopher Baladad, PharmD, BCIDP
Important article for #AMSSky, #TxID, #UTISky, and #IDSky in @cidjournal.bsky.social:

In neutropenic & non-neutropenic cancer patients w/ & w/o catheters, the absence of nitrite/leukocyte esterase or WBC<10 had high NPV for clinically significant bacteriuria

academic.oup.com/cid/advance-...
January 16, 2025 at 6:30 PM
#IDSky #PharmSky Patient with M. abscessus bacteremia on iHD.

1. How are you dosing amikacin in these patients?
2. Do you have specific peak goals?
3. Do you omit amikacin entirely?

If possible, you're willing to share protocols, that'd be extremely helpful!
January 8, 2025 at 6:50 PM
Where do we go from here with UTI WikiGuidelines and what do you use?

This study used cephalexin @ variable doses), median txt 10d, and cefazolin MIC of <=16 as susceptible. (CLSI cut-off for uUTI).

Personally, I use cephalexin 1000 mg PO QID x10-14d if cefazolin MIC <=2 for pyelonephritis.
Oral cephalosporins for pyelonephritis?!
🆕️⚡️⚡️COPY-ED
Multicenter, retrospective study
N=851
No difference in 14-day pyelonephritis treatment failure for oral cephalosporins* vs FQ/TMP-SMX for outpatient pyelonephritis in the ED #idsky #medsky
* Mostly cephalexin
www.sciencedirect.com/science/arti...
November 27, 2024 at 12:25 AM
#IDSky #PharmSky Pt w/ MTB on RIPE w/ rifampin 1200 mg QD (TDM ✅) Smear (+) x3 mo. Now with (+) serum galactomannan (0.5) and worsening O2 status. ID wants to treat for aspergillosis. Would you start posa and continue rifampin or convert to rifabutin and start posa?
November 21, 2024 at 7:14 PM
Presented on ED abx stewardship to our new ED physician group. Highlighted our ASB treatment rates, educated on our UTI guidelines, and showed our compliance with STI screening with CDC recommendations. How do you engage your ED teams for abx stewardship? #IDsky #Pharmsky #Medsky
November 15, 2024 at 2:02 AM
Reposted by Christopher Baladad, PharmD, BCIDP
Does your ED use Dalbavancin for SSTi? If so, what's your experience like? Is it any different from Linezolid with re: patient experience/admission/readmission/relapse/recurrence? #IDsky
November 10, 2024 at 7:12 PM
Hello #PharmSky #IDSky! I’m Chris, an ID pharmacist in San Diego, passionate about antimicrobial stewardship and resistance. Looking forward to connecting and learning with everyone here!
November 10, 2024 at 5:30 PM